NCR1 and non-small cell lung carcinoma: In vivo, NKp46+ ILC3s in non-small cell lung cancer (NSCLC) did not exhibit direct cytotoxicity but responded to tumors by producing IL-8 and TNF, and localized near tertiary lymphoid structures (TLS), which are associated with favorable prognosis (14).